Clinicopathological significance of MMP-7, laminin γ2 and EGFR expression at the invasive front of gastric carcinoma

Gastric Cancer

Volumn 17, Issue 3, 2014, Pages 412-422

  Sentani, Kazuhiro ^a   Matsuda, Miho ^a   Oue, Naohide ^a   Uraoka, Naohiro ^a   Naito, Yutaka ^a   Sakamoto, Naoya ^a   Yasui, Wataru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

EGFR; Gastric cancer; Invasive front; Laminin gamma 2; MMP 7

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; LAMININ; LAMININ GAMMA2; MATRILYSIN; MUCIN; UNCLASSIFIED DRUG; LAMC2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PHENOTYPE; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; TUMOR CELL; TUMOR INVASION; VERY ELDERLY; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; RECEPTOR, EPIDERMAL GROWTH FACTOR; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 84903739385     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-013-0302-6     Document Type: Article

References (57)

1. Yasui W, Sentani K, Sakamoto N, Anami K, Naito Y, Oue N. Molecular pathology of gastric cancer: research and practice. Pathol Res Pract. 2011;207:608-12.
2. Hohenberger P, Gretschel S. Gastric cancer. Lancet. 2003;362: 305-15. (Pubitemid 36936845)
3. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127:679-95. (Pubitemid 44781029)
4. Yokozaki H. Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol Int. 2000;50:767-77.
5. Tatematsu M, Tsukamoto T, Inada K. Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci. 2003;94:135-41. (Pubitemid 36575871)
6. Liotta LA. Tumor invasion and metastases-role of the extracellular matrix: rhoads memorial award lecture. Cancer Res. 1986; 46:1-7. (Pubitemid 16189019)
7. Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood). 2006;231:20-7. (Pubitemid 43063974)
8. Woessner JF Jr, Taplin CJ. Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem. 1988;263:16918-25. (Pubitemid 18268875)
9. Miyazaki K, Hattori Y, Umenishi F, Yasumitsu H, Umeda M. Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line. Cancer Res. 1990;50:7758-64.
10. Wilson CL, Matrisian LM. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol. 1996;28:123-36. (Pubitemid 26072499)
11. Yamamoto H, Adachi Y, Itoh F, Iku S, Matsuno K, Kusano M, et al. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res. 1999;59:3313-6. (Pubitemid 29334482)
12. Adachi Y, Yamamoto H, Itoh F, Arimura Y, Nishi M, Endo T, et al. Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers. Int J Cancer. 2001;95:290-4. (Pubitemid 32847038)
13. Liu XP, Kawauchi S, Oga A, Tsushimi K, Tsushimi M, Furuya T, et al. Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma. Jpn J Cancer Res. 2002;93:291-5. (Pubitemid 34464365)
14. Colognato H, Yurchenco PD. Form and function: the laminin family of heterotrimers. Dev Dyn. 2000;218:213-34. (Pubitemid 30349637)
15. Hintermann E, Quaranta V. Epithelial cell motility on laminin-5: regulation by matrix assembly, proteolysis, integrins and erbB receptors. Matrix Biol. 2004;23:75-85. (Pubitemid 38891522)
16. Miyazaki K. Laminin-5 (laminin-332): unique biological activity and role in tumor growth and invasion. Cancer Sci. 2006;97:91-8. (Pubitemid 43379475)
17. Pyke C, Romer J, Kallunki P, Lund LR, Ralfkiaer E, Dano K, et al. The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol. 1994;145:782-91.
18. Koshikawa N, Moriyama K, Takamura H, Mizushima H, Nagashima Y, Yanoma S, et al. Overexpression of laminin gamma2 chain monomer in invading gastric carcinoma cells. Cancer Res. 1999;59:5596-601. (Pubitemid 29526479)
19. Fukai Y, Masuda N, Kato H, et al. Correlation between laminin-5 gamma2 chain and epidermal growth factor receptor expression in esophageal squamous cell carcinomas. Oncology. 2005;69: 71-80. (Pubitemid 41207060)
20. Henning K, Berndt A, Katenkamp D, Kosmehl H. Loss of laminin-5 in the epithelium-stroma interface: an immunohistochemical marker of malignancy in epithelial lesions of the breast. Histopathology. 1999;34:305-9. (Pubitemid 29229984)
21. Masaki T, Sugiyama M, Matsuoka H, Abe N, Izumisato Y, Sakamoto A, et al. Coexpression of matrilysin and laminin-5 gamma2 chain may contribute to tumor cell migration in colorectal carcinomas. Dig Dis Sci. 2003;48:1262-7.
22. Okada K, Kijima H, Imaizumi T, et al. Stromal laminin-5 gamma2 chain expression is associated with the wall-invasion pattern of gallbladder adenocarcinoma. Biomed Res. 2009;30: 53-62.
23. Yamamoto H, Kitadai Y, Yamamoto H, Oue N, Ohdan H, Yasui W, et al. Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells. Gastroenterology. 2009;137:242-52 (52 e1-6).
24. Oka T, Yamamoto H, Sasaki S, Ii M, Hizaki K, Taniguchi H, et al. Overexpression of beta3/gamma2 chains of laminin-5 and MMP7 in biliary cancer. World J Gastroenterol. 2009;15: 3865-73.
25. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V. Induction of cell migration by matrix metal-loprotease-2 cleavage of laminin-5. Science. 1997;277:225-8. (Pubitemid 27446075)
26. Schenk S, Hintermann E, Bilban M, Koshikawa N, Hojilla C, Khokha R, et al. Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J Cell Biol. 2003;161:197-209. (Pubitemid 36459091)
27. Ono Y, Nakanishi Y, Gotoh M, Sakamoto M, Hirohashi S. Epidermal growth factor receptor gene amplification is correlated with laminin-5 gamma2 chain expression in oral squamous cell carcinoma cell lines. Cancer Lett. 2002;175:197-204. (Pubitemid 34001718)
28. Katoh K, Nakanishi Y, Akimoto S, Yoshimura K, Takagi M, Sakamoto M, et al. Correlation between laminin-5 gamma2 chain expression and epidermal growth factor receptor expression and its clinicopathological significance in squamous cell carcinoma of the tongue. Oncology. 2002;62:318-26. (Pubitemid 34914101)
29. Richter P, Bohmer FD, Hindermann W, Borsi L, Hyckel P, Schleier P, et al. Analysis of activated EGFR signalling pathways and their relation to laminin-5 gamma2 chain expression in oral squamous cell carcinoma (OSCC). Histochem Cell Biol. 2005;124:151-60. (Pubitemid 41429770)
30. Niki T, Kohno T, Iba S, Moriya Y, Takahashi Y, Saito M, et al. Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas. Am J Pathol. 2002;160:1129-41. (Pubitemid 34224599)
31. Sobin LH, Gospodarowicz MK. Wittekind CH eds: TNM classification of malignant tumors. 7th ed. Oxford: Wiley-Blackwell; 2009.
32. Lauren P. The Two Histological Main Types of Gastric Carcinoma: diffuse and So-Called Intestinal-Type Carcinoma. an Attempt at a Histo-Clinical Classification. Acta Pathol Microbiol Scand. 1965;64:31-49.
33. Mizoshita T, Tsukamoto T, Nakanishi H, Inada K, Ogasawara N, Joh T, et al. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J Cancer Res Clin Oncol. 2003;129:727-34. (Pubitemid 38002304)
34. Maehara Y, Okuyama T, Moriguchi S, Orita H, Kusumoto H, Korenaga D, et al. Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time. Cancer. 1992;70:392-5.
35. Yamao T, Shirao K, Ono H, Kondo H, Saito D, Yamaguchi H, et al. Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer. 1996;77:602-6. (Pubitemid 26055382)
36. Setala LP, Kosma VM, Marin S, Lipponen PK, Eskelinen MJ, Syrjanen KJ, et al. Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer. 1996;74:766-72. (Pubitemid 26300769)
37. Adachi Y, Oshiro T, Mori M, Maehara Y, Sugimachi K. Tumor size as a simple prognostic indicator for gastric carcinoma. Ann Surg Oncol. 1997;4:137-40. (Pubitemid 127729056)
38. Kakeji Y, Maehara Y, Tomoda M, Kabashima A, Ohmori M, Oda S, et al. Long-term survival of patients with stage IV gastric carcinoma. Cancer. 1998;82:2307-11. (Pubitemid 28283435)
39. Hochwald SN, Brennan MF, Klimstra DS, Kim S, Karpeh MS. Is lymphadenectomy necessary for early gastric cancer? Ann Surg Oncol. 1999;6:664-70.
40. Saito H, Osaki T, Murakami D, Sakamoto T, Kanaji S, Oro S, et al. Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer. Am J Surg. 2006;192:296-300. (Pubitemid 44223379)
41. Cianchi F, Cuzzocrea S, Vinci MC, Messerini L, Comin CE, Navarra G, et al. Heterogeneous expression of cyclooxygenase-2 and inducible nitric oxide synthase within colorectal tumors: correlation with tumor angiogenesis. Dig Liver Dis. 2010;42:20-7.
42. Alpizar-Alpizar W, Christensen IJ, Santoni-Rugiu E, Skarstein A, Ovrebo K, Illemann M, et al. Urokinase plasminogen activator receptor on invasive cancer cells: a prognostic factor in distal gastric adenocarcinoma. Int J Cancer. 2012;131:E329-36.
43. Tsutsumi S, Morohashi S, Kudo Y, Akasaka H, Ogasawara H, Ono M, et al. L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma. J Surg Oncol. 2011;103:669-73.
44. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, et al. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA. 2001;98:10356-61. (Pubitemid 32803024)
45. Spaderna S, Schmalhofer O, Hlubek F, Berx G, Eger A, Merkel S, et al. A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology. 2006;131:830-40. (Pubitemid 44307069)
46. Sleeman JP. The lymph node as a bridgehead in the metastatic dissemination of tumors. Recent Results Cancer Res. 2000;157: 55-81.
47. Allan GJ, Beattie J, Flint DJ. Epithelial injury induces an innate repair mechanism linked to cellular senescence and fibrosis involving IGF-binding protein-5. J Endocrinol. 2008;199:155-64.
48. Sauter G, Mirlacher M. Tissue microarrays for predictive molecular pathology. J Clin Pathol. 2002;55:575-6.
49. Hoos A, Urist MJ, Stojadinovic A, Mastorides S, Dudas ME, Leung DH, et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol. 2001;158:1245-51. (Pubitemid 32281288)
50. Lee HS, Cho SB, Lee HE, Kim MA, Kim JH, do Park J, et al. Protein expression profiling and molecular classification of gastric cancer by the tissue array method. Clin Cancer Res. 2007;13:4154-63. (Pubitemid 47105978)
51. Shinto E, Tsuda H, Ueno H, et al. Prognostic implication of laminin-5 gamma 2 chain expression in the invasive front of colorectal cancers, disclosed by area-specific four-point tissue microarrays. Lab Invest. 2005;85:257-66. (Pubitemid 40208929)
52. Takahashi S, Hasebe T, Oda T, et al. Cytoplasmic expression of laminin gamma2 chain correlates with postoperative hepatic metastasis and poor prognosis in patients with pancreatic ductal adenocarcinoma. Cancer. 2002;94:1894-901. (Pubitemid 34241129)
53. Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology. 2005;129:1375-83. (Pubitemid 41597379)
54. Ellis V, Pyke C, Eriksen J, Solberg H, Dano K. The urokinase receptor: involvement in cell surface proteolysis and cancer invasion. Ann N Y Acad Sci. 1992;667:13-31. (Pubitemid 23061557)
55. Amano S, Scott IC, Takahara K, Koch M, Champliaud MF, Gerecke DR, et al. Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 gamma 2 chain. J Biol Chem. 2000;275:22728-35. (Pubitemid 30646154)
56. Veitch DP, Nokelainen P, McGowan KA, Nguyen TT, Nguyen NE, Stephenson R, et al. Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin. J Biol Chem. 2003;278:15661-8. (Pubitemid 36799676)
57. Takami H, Sentani K, Matsuda M, Oue N, Sakamoto N, Yasui W. Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules. Pathobiology. 2012;79:154-61.